Description: This session at the 2004 Valuation Actuary Symposium provides an overview of statutory valuation issues for life and annuity products including the Actuarial Opinion and Memorandum Regulation, variable products reserving standard, adoption of 2001 CSO, C-3 Phase II RBC project and nonforfeiture changes.

Description: Panelists of this teaching session discuss: [1] policyholder and company behavior and its impact on model and assumptions, [2] model purpose and structure, data collection, and behavior models, and [3] the modeling process, including objectives, considerations, constraints, and validation. Session 10 of the 1996 Valuation Actuary Symposium.

Description: This session at the 1998 Valuation Actuary Symposium discusses issues related to variable and fixed deferred annuity modeling.

Description: 2003 Valuation Actuary Symposium, San Diego, CA. In this open forum participants' questions were addressed by experts in the field. Some of the questions: 1. How does actuarial practice develop with regard to questions about interim results and asset-adequacy analysis projections? 2. If the present value measures used in typical asset-adequacy evaluation include a favorable adequacy opinion, are there patterns of interim results that under commonly accepted actuarial practice would require additional reserves to be established? 3. What is the most extreme stochastic modeling that you have seen? How many scenarios on how large a block, on how complex a model, on how many PCs or what type of computer that ran for over how many days? 4. Is codification retroactive? Does it impact any previous reserving methodologies put in place on policies issued before codification was effective? 5. What are your individual views on whether the federal government should provide a backstop to group or individual life insurance to handle terrorism catastrophes? 6. What are your thoughts are on the move toward stochastic methods for setting reserves?

Description: Panelists discuss: [1] Practice Bulletin 8 that was written for FAS 97, [2] Purchase GAAP [PGAAP], and [3] GAAP for re-entry term products. Session 10 of the 1991 Valuation Actuary Symposium.

Description: This presentation is a panel discussion, session number 2PD, from the 2002 Valuation Actuary Symposium, held September 19-20 in Lake Buena Vista, FL. The panelists introduce major life and annuity statutory and GAAP valuation issues, which are covered in depth at subsequent sessions. There is also a brief update on activities of the International Accounting Standards Board [IASB]. Statutory topics include the draft National Association of Insurance Commissioners [NAIC] Actuarial Guideline MMMM for variable products with guaranteed living benefits, amendments to the Actuarial Opinion and Memorandum Regulation [AOMR], Regulation XXX mortality factors, and codification update, potential changes to the Standard Valuation Law, risk-based capital, and adoption of the 2001 CSO Mortality Table for valuation. GAAP topics include Statement of Financial Reporting Standards [SFAS] 133, 141, and 142, and two draft AICPA Statements of Position [SOP], one on nontraditional, long-duration products and another on internal replacements. Discussion from participants is included.

Description: From a session at the 2001 Valuation Actuary Symposium, held in Lake Buena Vista, Florida, November 29-30, 2001 Discussion of financial restructuring trends and the impact of those trends on the insurance industry and challenges for those companies that have recently experienced some form of financial restructuring.

Description: 1996 Valuation Actuary Symposium. In this teaching session on liability modeling, the panelists discussed the key aspects of identifying and gathering the data required to construct models, the model building process including objectives and considerations, and the modeling process from the standpoint of policyholder and company behaviors.

Description: 2003 Valuation Actuary Symposium, San Diego, CA. This session provided an overview of current statutory valuation issues pertaining to life and annuity products. Topics included: 1. Actuarial opinion and memorandum regulation amendments. 2. Progress on variable products reserving standards. 3. Regulation XXX mortality factors. 4. Adoption of the 2001 CSO. 5. Progress on the C-3 Phase II RBC project. 6. An update on annuity and life nonforfeiture.

Description: Panelists provide background and updates on a number of statutory issues relating to life and annuity products, including statutory codification implementation, Actuarial Guideline MMMM, Actuarial Guideline AXXX and implications of the movement to the 2001 CSO table. Changes to federal reporting requirements, through the Sarbanes-Oxley Act, are briefly discussed relative to the recent accounting problems in the news. From the 2002 Record of Society of Actuaries, Volume 28, No. 3. Session 78OF of the Boston Annual Meeting.